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Biological functions of entactin. Entactin is a sulfated multidomain
glycoprotein component of basement membranes. The molecule con-
sists of 1217 amino acids which are organized into two terminal globular
domains linked by a rod-like structure largely composed of four EGF-
and one thyroglobulin-like cysteine-rich homology repeats. Entactin
binds to laminin, collagen IV, fibrinogen, and fibronectin. In the parietal
endoderm M1536-B3 cell line, the laminin-entactin complex is formed
intracellularly and transported in membrane enclosed vesicles to the
extracellular compartment. Transfection of human choriocarcinoma
JAR cells, which do not synthesize entactin, with entactin cDNA
results in the synthesis and insertion of entactin into the extracellular
matrix where it becomes associated with laminin and collagen IV.
Indirect immunofluorescent staining also reveals that entactin co-
localizes with fibronectin in the extracellular matrix of the embryonal
carcinoma-derived 4CQ cell line. These observations suggest that
entactin plays an important role in the assembly and properties of
diverse extracellular matrices. In addition, entactin binds to immobi-
lized fibrinogen, and more specifically, to the Aa and Bf3 chains. The
binding of radiolabeled entactin to immobilized fibrinogen is not depen-
dent on metal ions, and is inhibited by antibodies against either
fibrinogen or entactin, soluble fibrinogen, and unlabeled entactin. This
interaction combined with the chemotactic and phagocytic promoting
activities of entactin may be important in hemostasis and wound
healing.
bind calcium ions, form a tight stoichiometric complex with
laminin [5—7, 9], and interact with type IV collagen [7, 10],
fibronectin [11, 12] and fibrinogen [13]. Furthermore, the mol-
ecule promotes chemotaxis and phagocytosis, most likely
through specific integrin receptors [14].
Methods
Materials
Human plasma fibrinogen (T3879), bovine albumin, and rab-
bit IgG were obtained from Sigma Chemical Co. (St. Louis,
Missouri, USA). Tran35S-label was purchased from ICN Bio-
medical (Costa Mesa, California, USA). Immobilon was pur-
chased from Millipore (Bedford, Massachusetts, USA). Human
plasma fibronectin was obtained from Collaborative Research,
Inc. (Bedford, Massachusetts, USA). Recombinant entactin
and metabolically-radiolabeled entactin were purified from Sf9
cells infected with 14-6 recombinant baculovirus as previously
described [12].
Immunological reagents
The major components of the basal lamina include collagen
IV, laminin, proteoglycans, entactin, tenascin and fibronectin
[1—4]. These and other associated molecules form a macromo-
lecular assembly which organizes cells into tissues and influ-
ences their behavior. This supramolecular structure varies in
different tissues and at different stages of development. The
temporal appearance of the individual molecules and their
ability to associate both covalently and non-covalently deter-
mine the physical and functional properties of the basal lamina.
The pathway for assembly and the contributions of each of the
components to the properties of the basal lamina are subjects of
intensive investigation. In this communication, the focus is on
the role of entactin in extracellular matrix assembly and its
potential contributions to the biological functions of the basal
lamina. Entactin is a sulfated glycoprotein of M1 150,000 whose
structure and biological properties have been reviewed recently
[5]. The murine molecule consists of 1217 amino acids which
are organized into two terminal globular domains linked by a
rod-like structure largely composed of EGF- and thyroglobulin-
like, cysteine-rich homology repeats [6, 7]. Human entactin has
similar features and is 84% identical to the murine entactin [8].
The murine entactin has been shown to support cell adhesion,
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Rabbit polyclonal antisera were raised against entactin and
the laminin B chains purified from mouse Ml536-B3 cells [15,
16]. Antiserum against mouse type IV collagen from the Engel-
breth-Hoim Swarm sarcoma was obtained from Dr. Hynda
Kleinman, National Institute of Dental Research, NIH. Anti-
human fibrinogen antiserum (fractionated goat Ig) and mouse
monoclonal anti-fibronectin antibody were from Sigma. Goat
anti-human fibrinogen degradation product D antiserum and
goat anti-human fibrinogen degradation product E antiserum
were purchased from ICN Biomedical. Anti-human fibronectin
polyclonal antibodies was obtained from Collaborative Re-
search, Inc. Alkaline phosphatase-conjugated goat anti-rabbit
secondary antibody used in immunoblotting was from Bio-Rad
(Richmond, California, USA). Fluorescein- and rhodamine-
conjugated secondary antibodies were purchased from Cappel
(West Chester, Pennsylvania, USA) and Boehringer Mannheim
Biochemicals (Indianapolis, Indiana, USA).
Cells and cell culture
M1536-B3 and 4CQ cells were isolated from differentiated
embryonal carcinoma PCC4-F cells and grown as previously
described [17]. The human choriocarcinoma cell line JAR [18]
was purchased from the American Type Culture Collection
(Rockville, Maryland, USA) and maintained in Dulbecco's
modified Eagle's medium (DMEM) supplemented with 10%
FBS in a humidified, 5% CO2 atmosphere at 37°C.
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Vector construction
The construction of pEN, which contains the complete
mouse entactin open reading frame, has been described [19].
The 3877 bp insert of pEN was cloned into the /3-actin promoter
expression vector pH/3APr-neo-1 120] in two stages. A BglII
linker was attached to the 5' end of the insert and a BamHl
linker was attached to the 3' end of the insert as detailed by
Tsao et a! [19]. The 5' BglII/BamHl fragment, nt 1-994 [6], was
cloned into the BamHl site of pH/3APr-neo-l; the resulting
plasmid was cut with BamHl and ligated to the 3' BamHl
fragment (nt 995-3877) to give p444-EN. Restriction enzyme
digestion was used to confirm that the entactin cDNA was in the
sense orientation with respect to the /3-actin promoter.
Transfection procedures
The cells were transfected with p444-EN DNA using cationic
lipid solution (Lipofectin, BRL, Gaithersburg, Maryland, USA)
by a modification of the supplier's protocol. Eight micrograms
of cesium-banded p444-EN DNA and 30 d of Lipofectin were
diluted in separate 1,5 ml aliquots of serum-free DMEM,
combined, and added to one 60 mm dish of JAR cells, which
had been seeded the day before and washed twice with serum-
free DMEM immediately prior to the transfection. After 19
hours of exposure, the DNA/Lipofectin solution was removed
and replaced with 4 ml of fresh medium containing 10% FBS.
The following day the cells were split into five 60 mm dishes and
48 hours after addition of the DNA, the antibiotic G4l8 (Gibco,
Grand Island, New York, USA) was added to a final concen-
tration of 400 p.g/ml. Colonies were picked 12 days later and
maintained in 250 g/ml G4 18 thereafter.
Immunofluorescent staining cells
Cells were cultured on flame-sterilized 22 mm2 glass cover-
slips then fixed in 1:1 ethanol/acetone or ethanol. The cover-
slips were incubated with primary antibodies diluted in PBS.
The coverslips were washed with PBS and incubated with
species-specific fluorescein- or rhodamine-conjugated second-
ary antibodies, diluted in PBS, as indicated in the figure
legends. The coverslips were mounted in 0.025 M glycine, pH
8.5, in 75% glycerol and the cells were observed using a Zeiss
fluorescent microscope equipped with a 40 x neofluor objective
and fluorescein and rhodamine filters. Representative fields
were photographed using Kodak Tri-X 400 film.
Electron microscopy
The intracellular localization of entactin in M1536-B3 cells
was determined by immunogold staining with antibodies against
entactin and laminin. Cells were grown as described above and
collected in 0.15 M sodium cacodylate buffer, pH 7.4. The cell
pellet was fixed for 30 minutes at 00 in 4% formaldehyde plus
0.2% glutaraldehyde dissolved in 0.1 M sodium cacodylate
buffer, pH 7.0. The fixed cells were rinsed briefly with 0.15 M
cacodylate buffer, pH 7.0, and dehydrated in a 30 to 90% graded
series of methanol at 0°. The sample was infiltrated with LR
Gold (The London Resin Co, Surrey, UK) and the resin
polymerized under long wavelength UV light at 4° for 24 hours,
and at room temperature for an additional 24 hours. The block
was trimmed and ultrathin sections cut with a glass knife. The
sections were transferred to nickel electron microscope grids
and stained with rabbit polyclonal anti-mouse entactin or anti-
mouse laminin antibodies followed by auroprobe EM gold
labeled secondary antibody as recommended by the manufac-
turer (Janssen Biotech, Olen, Belgium). The samples were
exposed to 0s04 vapor, stained with 3% aqueous uranyl acetate
and then with Reynolds lead citrate and examined in a Phillips-
300 electron microscope.
Electrophoresis and immunoblot
All protein samples, unless otherwise noted, were reduced,
electrophoresed and transferred to Immobilon as described
previously [21, 22]. After transfer, one of duplicate samples was
stained with 0.1% (wt/vol) Amido Black in 45% (vol/vol)
methanol-lO% (vol/vol) acetic acid in water and destained with
the same solvent for protein visualization. The other Immobilon
strip was incubated with 5% (wt/vol) nonfat dry milk in TBST at
room temperature for at least one hour, followed by incubation
with the primary antibody (diluted 1:5,000) for one hour with
gentle shaking. The strip was next washed three times with
TBST and incubated for another hour with alkaline phos-
phatase-conjugated secondary antibody (diluted 1:2,000) in 5%
nonfat milk/TBST. The strip was washed as before and incu-
bated with 33 jsl of 5% nitroblue tetrazolium in 70% dimethyl
formamide and 16.5 d of 5% 5-bromo-4-chloro-3-indolyl phos-
phate in 100% dimethyl formamide/5 ml of 0.1 M NaCl-0.005 M
MgC12-0. 1 M Tris-HC1 (pH 9) until the desired intensity of color
had developed.
Blot binding assay
This assay was performed as previously described [13].
Fibrinogen chains were separated by 5 to 7.5% SDS-PAGE
under reducing conditions and transferred to an Immobilon
sheet as described previously. The Immobilon sheet was cut
into multiple strips, one of which was stained with Amido Black
and destained as described above. The other strips were incu-
bated with 5% (wt/vol) BSA in TBS for four hours or longer at
room temperature. After blocking, the Immobilon strips were
incubated for four hours at room temperature or overnight at
4°C with the purified 35S-labeled-entactin solution which had
been diluted, unless otherwise indicated, one to five in 5%
BSA/TBS. At the end of incubation, the strips were rinsed six
times (each for 5 mm or longer) in TBS to remove unbound
proteins and then dried in air at ambient temperature. The
labeled fibrinogen chains were visualized by autoradiography
and the radioactivity of the 35S-entactin bound to each chain
was quantitated with an AMBIS Radioanalytic Imaging System
(AMBIS Systems Inc., San Diego, California, USA) following
the manufacturer's instructions. To assess whether the binding
was divalent cation-dependent, strips of the Immobilon were
incubated with 35S-entactin in the presence of 5 mri EDTA or 1
mM CaCl2-l mr'vi MgC12-1 ms MnCl2, followed by rinsing in
TBS containing 5 m EDTA or 1 mM CaCI2-1 mM MgC12-1 mM
MnCl2. In the inhibition studies, each of the Immobilon strips
was incubated with 2 ml 5% BSA/TBS containing 5 mg/mi
rabbit IgG, a 1:4 dilution of anti-fibrinogen antiserum, a 1:4
dilution of anti-fibrinogen degradation product E antiserum, a
1:4 dilution of anti-fibrinogen degradation product D antiserum,
a 1:10 dilution of anti-entactin antiserum, 15 mg/ml fibrinogen or
1.2 mg/mI unlabeled recombinant entactin for three hours prior
to the addition of 35S-entactin.
Chung et a!: Functions of entactin 15
Fig. 1. Light micrographs of M1536-B3 cell
aggregates. Semi-thin sections were cut from
blocks prepared for electron microscopy. The
sections were mounted on glass slides and
stained. A, 2 hours after seeding; B, 12 hours
culture; C, 3 day; and D, 6 day cultures,
respectively.
Results
Role of entactin in extracellular matrix assembly
Synthesis of the laminin-entactin complex by M1536-B3 cells.
The parietal endoderm-like M1536-B3 cells synthesize an extra-
cellular matrix that contains laminin, entactin, and heparan
sulfate proteoglycan [15, 16, 23]. The temporal events which
lead to the assembly of laminin and entactin were examined in
M1536-B3 cells in suspension culture. The cells plated in Petri
dishes initially form small aggregates which proliferate and
deposit an extracellular matrix at the basal surface of the cells.
As the cells continue to synthesize and secrete the matrix
molecules, the aggregate increases in size to yield a monolayer
firmly attached to the extracellular matrix core (Fig. 1). The
cells which constitute the aggregate are highly organized as may
be seen from a thin section through a small aggregate (Fig. 2).
The cells are polarized, rich in internal organelles, and contain
an extensive network of endoplasmic reticulum and Golgi
complexes. They are closely apposed and junctional complexes
are evident. This organization probably mimics the behavior of
the cells in vivo. To obtain further information on the pathway
of exocytosis of laminin and entactin, their intra- and extracel-
lular localization was examined by immunoelectron micros-
copy. The colocalization of laminin and entactin in the extra-
cellular matrix, as reflected by the juxtaposition of the two
different sized gold particles, is apparent in Figure 3. This
finding correlates with previous work which demonstrated that
laminin and entactin form a tight stoichiometric complex in this
matrix. The intracellular staining reveals that laminin and
entactin are present together in membrane enclosed vesicles
close to the plasma membrane. This observation indicates that
the two molecules are co-transported to the extracellular com-
partment, most likely as a preformed complex. The experi-
ments taken together suggest that the initiation of synthesis of
the organized matrix occurs by the aggregation of the Ml536-B3
cells, followed by polarization of the cells which stimulates the
synthesis and intracellular assembly of the laminin-entactin
complex. The complex is exocytosed via membrane bound
vesicles and inserted into the matrix. The matrix expands by
continual addition of material and undergoes further modifica-
tion in the extracellular environment.
Incorporation of entactin into the extracellular matrix of JAR
cells. The extracellular matrix of JAR cells does not contain
entactin (Fig. 4A) but does contain laminin (Fig. 4C) and
collagen IV (Fig. 4E). Transfection of the cells with a vector
containing entactin cDNA resulted in the isolation of a stable
G4 18-resistant transfectant that synthesizes entactin messenger
RNA. Cells from one clone synthesize and deposit entactin into
the extracellular matrix as shown in Figure 4B. In addition to
entactin, the cells continue to synthesize laminin (Fig. 4D) and
collagen IV (Fig. 4F). Examination of the staining patterns
reveals that in the transfected clone, laminin, entactin and
collagen are co-localized in a punctate pattern predominantly at
the cell boundaries. The implication of these experiments is that
mouse entactin synthesized under the control of the beta-actin
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Fig. 2. Electron micrographs of M1536-B3
cells. Cells were cultured in Petri dishes for 3
days then fixed and processed as described in
the Methods section. The extracellular matrix
(ECM) is surrounded by the cells which are
polarized with the endoplasmic reticulum (ER)
predominantly located on the outer aspect of
the aggregated cells and the Golgi (G) closer
to the cavity of the aggregate, The cells are
held together by tight junctional complexes
(open arrows).
Fig. 3. Immunoelectron micrograph of
M1536-B3 cells. The cells were processed as
described in the Methods section. Thin
sections were stained on opposite sides with
anti-entactin and anti-laminin antibodies.
Entactin (large gold particles indicated by
open arrows) co-localized with laminin (small
gold particles, solid arrow heads) in both
membrane bound vesicles (TV) and in the
ECM. PM indicates the plasma membrane.
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promoter can be incorporated readily into the extracetlular entactin can be inserted into the extracellular matrix of these
matrix of human cells and may modulate the organization of cells by interacting with fibronectin or the cell surface.
both laminin and collagen IV in this matrix.
Co-localization of entactin and fibronectin in the extracellu-
lar matrix of4CQ cells. 4CQ cells are derived from a differen- Potential role of entactin in hemostasis
tiated culture of mouse embryonal carcinoma cells. These cells Binding of entactin tofibrinogen. The mechanism by which a
have previously been shown not to synthesize laminin, how- fibrin clot is stabilized by association with the endothelial
ever, the type of extracellular matrix which they synthesize has basement membrane is not well understood. Since fibrinogen
not been examined in detail. As may be seen in Figure 5, the has not been shown to bind to laminin or type IV collagen, two
extracellular matrix of these cells contain both fibronectin (Fig. of the major components of the endothelial basement mem-
5A) and entactin (Fig. 5B). Furthermore, in this experiment the brane, its interaction with entactin, another major component,
staining pattern of the two molecules overlap. It appears that was explored. The data shown in Figure 6 clearly show that
k1n '.. Ac.
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Fig. 4. Detection of laminin, entactin and
type IV collagen deposited in cell layers by
indirect immunofluorescence. JAR cells (A, C,
and E) and JAR-EN cells (B, D and F) grown
on coverslips were incubated with anti-
entactin antiserum (A and B). anti-laminin B
chain antiserum (C and D) or anti-type IV
collagen antiserum (E and F).
Immunoreactivity was visualized after
incubation with fluorescein-conjugated goat
anti-rabbit secondary antibody (entactin and
laminin) and rhodamine-conjugated secondary
goat anti-rabbit antibody (type IV collagen).
The cells in E and F were incubated in the
presence of ascorbate (10 mg/mI).
Magnification 400x.
radiolabeled recombinant entactin bound tightly to the immo-
bilized Aa and Bf3 chains of fibrinogen. There was no binding to
the y chain. As summarized in Table 1 for the Aa chain, the
binding was specific, since it could be inhibited by antibodies
against fibrinogen or entactin, soluble fibrinogen or unlabeled
entactin. The presence of EDTA did not affect the binding
significantly, indicating that metal ions were not required for the
binding activity. Similar results were obtained for the Bf3chain.
Additional experiments have shown that the binding is satura-
ble with an apparent half maximal binding at iO M fibrinogen.
Discussion
The results described here as well as other previously pub-
lished work have begun to define more clearly the biological
activities of entactin. These include: (a) extracellular matrix
assembly; (b) a role in hemostasis and wound healing; (c)
enhancement of cell attachment; and (d) enhancement of che-
motaxis and phagocytosis.
The presence of entactin in the basement membranes of
diverse tissues has long been established and its tight non-
covalent binding to laminin has been well documented [1, 5].
Solid phase binding assays furthermore indicate that entactin
can bind to collagen IV as well as to fibronectin [10—12]. We
have provided new data which suggest that these in vitro
interactions have their counterparts in normal cellular physiol-
ogy. The cell line M1536-B3 synthesizes a defined extracellular
matrix that maintains the ultrastructural characteristics of nor-
mal basement membranes, although the matrix does not contain
collagen IV [23, 24]. The assembly of this matrix appears to be
initiated within the cell and completed in the extracellular
compartment. Previous pulse-chase experiments in conjunction
with chain-specific laminin antibpdies have suggested that the
laminin-entactin complex is assembled in the endoplasmic
reticulum cisternae. Those results are supported by the obser-
vation that the two molecules can be detected in the same
intracellular membrane bound compartments. In the extracel-
lular compartment, the association of the matrix is dependent
on the metal ion-requiring interactions between laminin and the
laminin-entactin complex. The calcium binding properties of
entactin and laminin are particularly important in these initial
reactions [9, 19, 25—27]. The stabilization of the laminin-entac-
tin complexes probably occurs through the mediation of trans-
glutaminase, as suggested by the catalysis of cross-linking of
entactin and the laminin-entactin complex in vitro by transglu-
taminase [13, 281. Although the synthesis of the extracellular
matrix in M1536-B3 cells begins intracellularly with the forma-
tion of the laminin-entactin complex, in other systems this may
not be required. It has recently been shown that in the devel-
oping mouse eye, different cells are responsible for the synthe-
sis of each molecule during the elaboration of the pigmented
epithelium basement membrane, and in this situation, the
association of the molecules in the matrix takes place extracel-
lularly [29]. The alternate pathways for assembly may reflect
the need for specific organizational patterns in the matrix. The
role of entactin in modulating the extracellular matrix was
examined further in the human choriocarcinoma JAR cell. The
A B
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Fig. S. Co-localization of entactin andfibronectin in 4CQ extracellular matrix. Monolayer cultures of 4CQ cells were grown on glass cover slips,
fixed with ethanol and stained with a mixture of the rabbit anti-entactin antiserum and mouse anti-fibronectin monoclonal antibody as described
in the Methods section. The cells were viewed with a Zeiss microscope using fluorescent optics and photographed at 400X magnification. Panel
A was stained with rhodamine and panel B with fluorescein.
introduction of entactin cDNA into these cells resulted not only
in the synthesis and deposition of entactin in the matrix but also
in the apparent reorganization of laminin and collagen IV. This
reorganization has the potential to modify the distribution of the
integrin receptors for the extracellular matrix components and
thereby affect the morphology and behavior of the cell.
Entactin has been shown to be synthesized by non-epithelial
cells such as fibroblasts, and since fibronectin is a major gene
product of normal fibroblasts it seemed likely that the two
molecules could associate in the extracellular matrix. Indeed,
this turned out to be true when the extracellular matrix of the
mouse embryonal carcinoma-derived cell 4CQ was examined.
Solid phase binding experiments support the interaction of the
molecules [11, 12]. The physiological relevance of the associa-
tion remains to be determined, although it is tempting to suggest
that the role of entactin is to facilitate the organization of
fibronectin fibers or the converse. Furthermore, entactin could
influence the interaction of fibronectin with other macromole-
cules such as collagen and heparin and even form a bridge
between fibronectin and laminin in normal tissues during devel-
opment. The cell binding properties of entactin could also act in
synergy with fibronectin.
The molecular interactions involved in the attachment of the
fibrin clot to the endothelial basement membrane have not been
fully elucidated. The present studies on the binding of entactin
to the Aa and B/3 chains of fibrinogen may be relevant to this
issue. The interaction between entactin and fibrinogen appears
to be quite specific since the binding is saturable and can be
inhibited by anti-entactin antiserum or anti-fibrinogen anti-
serum but not the unrelated rabbit IgG. Soluble fibrinogen or
Fig. 6. Binding of 35S-labeled recombinant entactin to fibrinogen An-
and B 13-chains transferred to Immobilon from an SDS polyacrylamide
gel. Fibrinogen was electrophoresed on a 5 to 7.5% reducing SDS
polyacrylamide gel and transferred to Immobilon. Lane I, an Immo-
bilon strip stained with Amido Black following transfer of the proteins
from the gel. Lane 2, autoradiogram of the Immobilon strip containing
fibrinogen An, B13 and y chains following incubation with 35S-labeled
recombinant entactin.
SnI-
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Additions
None
IgG
EDTA
Anti-E 0
Anti-D 0
Anti-fibrinogen 0
Fibrinogen 14
Entactin 12
Anti-entactin 0
Inhibition of binding of radiolabeled recombinant entactin to solid
phase fibrinogen An chain with unlabeled entactin, soluble fibrinogen,
anti-entactin and anti-fibrinogen antisera. The inhibition experiments
were carried out as described in the Methods section. The radioactivity
of 35S-entactin bound to solid phase fibrinogen Aa chain was quanti-
tated using an AMBIS Radioanalytic Imaging System. Binding is
expressed as percent of control. Abbreviations are: Anti-E, anti-human
fibnnogen degradation product E antibody; Anti-D, anti-human fibrin-
ogen degradation product D antibody.
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Table 1. Inhibition of binding of entactin to fibrinogen
entactin can also compete with the binding of radiolabeled
entactin to immobilized fibrinogen. Preliminary results have
suggested that entactin can be covalently cross linked to
fibrinogen, possibly through the Aa chain by transglutaminase
[13]. This cross linking may play a role in stabilizing fibrin clots
during hemostasis and in clot retraction at a later stage. In
addition, entactin could modulate the interaction of fibrinogen
with platelets by masking or exposing functional domains.
Further work is required to determine the sites of interaction
between the two molecules and to evaluate the significance of
these observations in vivo.
